N@N

David Macdonald Maintained (AMED) at Hold with Increased Target to $101 on, Jun 27th, 2023

David Macdonald of Truist Securities, Maintained "Amedisys, Inc." (AMED) at Hold with Increased Target from $97 to $101 on, Jun 27th, 2023.

David has made no other calls on AMED in the last 4 months.

There are 5 other peers that have a rating on AMED. Out of the 5 peers that are also analyzing AMED, all agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Jonathan Yong of "Credit Suisse" Downgraded from Buy to Hold and Decreased Target to $100 on, Tuesday, June 6th, 2023
• Sarah James of "Cantor Fitzgerald" Maintained at Hold with Increased Target to $100 on, Tuesday, June 6th, 2023
• Gary Taylor of "TD Cowen" Maintained at Hold with Decreased Target to $84 on, Monday, May 8th, 2023
• Steve Valiquette of "Barclays" Maintained at Hold with Decreased Target to $88 on, Friday, May 5th, 2023
• Scott Fidel of "Stephens & Co." Reiterated at Hold and Held Target at $103 on, Thursday, May 4th, 2023

Contributing Sources

---